Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 13
Original Research
Empagliflozin in Type 2 Diabetes Mellitus Patients with High Cardiovascular Risk: A Model-Based Cost-Utility Analysis in China
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,686 | Dovepress* | 7,088+ | 999 | 8,087 | |
| PubMed Central* | 598 | 201 | 799 | ||
| Totals | 7,686 | 1,200 | 8,886 | ||
| *Since 11 August 2020 | |||||
View citations on PubMed Central and Google Scholar